BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 25437067)

  • 1. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
    Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
    Wen S; Liu H; Cai H; Shen M; Shi X
    Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy.
    Wang Y; Guo R; Cao X; Shen M; Shi X
    Biomaterials; 2011 Apr; 32(12):3322-9. PubMed ID: 21315444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers.
    Zhang M; Guo R; Kéri M; Bányai I; Zheng Y; Cao M; Cao X; Shi X
    J Phys Chem B; 2014 Feb; 118(6):1696-706. PubMed ID: 24467521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging.
    Zhu J; Wang G; Alves CS; Tomás H; Xiong Z; Shen M; Rodrigues J; Shi X
    Langmuir; 2018 Oct; 34(41):12428-12435. PubMed ID: 30251859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer-entrapped gold nanoparticles modified with RGD peptide and alpha-tocopheryl succinate enable targeted theranostics of cancer cells.
    Zhu J; Fu F; Xiong Z; Shen M; Shi X
    Colloids Surf B Biointerfaces; 2015 Sep; 133():36-42. PubMed ID: 26070049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles.
    Zhu J; Zheng L; Wen S; Tang Y; Shen M; Zhang G; Shi X
    Biomaterials; 2014 Aug; 35(26):7635-46. PubMed ID: 24927683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core-shell tecto dendrimers formed via host-guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery.
    Wang J; Li D; Fan Y; Shi M; Yang Y; Wang L; Peng Y; Shen M; Shi X
    Nanoscale; 2019 Nov; 11(46):22343-22350. PubMed ID: 31728477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
    Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional dendrimer-entrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors.
    Chen Q; Wang H; Liu H; Wen S; Peng C; Shen M; Zhang G; Shi X
    Anal Chem; 2015 Apr; 87(7):3949-56. PubMed ID: 25768040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-modified PAMAM-Fe3O4-doxorubicin triads with the potential for improved therapeutic efficacy: generation-dependent increased drug loading and retention at neutral pH and increased release at acidic pH.
    Nigam S; Chandra S; Newgreen DF; Bahadur D; Chen Q
    Langmuir; 2014 Feb; 30(4):1004-11. PubMed ID: 24446987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel, nano-sized, liposome-encapsulated polyamidoamine dendrimer derivatives facilitate tumour targeting by overcoming the polyethylene glycol dilemma and integrin saturation obstacle.
    Li G; Song YZ; Huang ZJ; Chen K; Chen DW; Deng YH
    J Drug Target; 2017 Sep; 25(8):734-746. PubMed ID: 28452577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.
    Zhang M; Guo R; Wang Y; Cao X; Shen M; Shi X
    Int J Nanomedicine; 2011; 6():2337-49. PubMed ID: 22072871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells.
    Cao X; Tao L; Wen S; Hou W; Shi X
    Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide (131)I-labeled multifunctional dendrimers for targeted SPECT imaging and radiotherapy of tumors.
    Zhu J; Zhao L; Cheng Y; Xiong Z; Tang Y; Shen M; Zhao J; Shi X
    Nanoscale; 2015 Nov; 7(43):18169-78. PubMed ID: 26477402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.